Examination Report |
1 | Additional Representation Sheet | 23 Dec 2008 |
1 | Authorization Document (POA) | 23 Dec 2008 |
10 | TM-44 | 18 Oct 2010 |
10 | TM-5 | 18 Oct 2010 |
11 | Authorization Document (POA) | 30 Nov 2010 |
11 | Correspondence | 30 Nov 2010 |
12 | Correspondence | 30 Nov 2010 |
12 | TM-16 | 30 Nov 2010 |
13 | Authorization Document (POA) | 30 Nov 2010 |
13 | Correspondence | 30 Nov 2010 |
13 | TM-16 | 30 Nov 2010 |
14 | TM-6 | 18 Sep 2012 |
15 | Correspondence | 21 Dec 2012 |
15 | TM-6 | 21 Dec 2012 |
16 | Correspondence | 21 Dec 2012 |
16 | TM-6 | 21 Dec 2012 |
17 | Correspondence | 30 Mar 2014 |
18 | TM-56 | 22 May 2014 |
19 | TM-56 | 26 Jun 2014 |
2 | Authorization Document (POA) | 23 Dec 2008 |
2 | TM-1 | 23 Dec 2008 |
20 | TM-56 | 08 Aug 2014 |
21 | TM-56 | 01 Sep 2014 |
22 | TM-56 | 15 Jan 2015 |
23 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 06 Dec 2022 |
24 | Order | 06 Feb 2023 |
25 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 20 Feb 2023 |
26 | Certificate | 21 Feb 2023 |
27 | TM-R(RENEWAL OF TRADE MARK) | 24 Feb 2023 |
28 | Order | 11 Mar 2023 |
3 | Additional Representation Sheet | 23 Dec 2008 |
3 | TM-1 | 23 Dec 2008 |
4 | Authorization Document (POA) | 03 Sep 2010 |
4 | Journal Copy | 03 Sep 2010 |
5 | Correspondence | 03 Sep 2010 |
5 | Journal Copy | 03 Sep 2010 |
6 | Correspondence | 03 Sep 2010 |
6 | TM-5 | 03 Sep 2010 |
7 | Authorization Document (POA) | 03 Sep 2010 |
7 | TM-5 | 03 Sep 2010 |
8 | Journal Copy | 18 Oct 2010 |
8 | TM-5 | 18 Oct 2010 |
9 | Journal Copy | 18 Oct 2010 |
9 | TM-44 | 18 Oct 2010 |
9 | TM-5 | 18 Oct 2010 |
1 | Hearing Notice | 14633573 | 5826854 | 13 Jan 2023 |
2 | Hearing Notice | 14741506 | 5850246 | 03 Feb 2023 |
3 | RENEWAL INTIMATION LETTER | 14867443 | 28 Feb 2023 |
The application for Doxulip was made on 23 December 2008.
The trademark applicant for Doxulip is UNITED BIOTECH.
Doxulip is applied in class(es) 5.
Application for Doxulip is on Registered stage.
Application Id allotted to Doxulip is 1767254.
Trademark agent or attorney for the application is Sim & San Advocates.
Doxulip filed with the Intellectual property office as a WORD.